HNA antibody-mediated neutrophil aggregation is dependent on serine protease activity

Vox Sanguinis

Volumn 109, Issue 4, 2015, Pages 366-374

  Berthold, T ^a   Schubert, N ^a   Muschter, S ^a   Rohr, M ^a   Wesche, J ^a   Reil, A ^b   Bux, J ^c   Bakchoul, T ^a   Greinacher, Andreas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b Institute Springe   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Aggregation; HNA 2; HNA 3a; Inhibitors; Neutrophil; TRALI

Indexed keywords

4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; ALLOANTIGEN; ASPARTIC PROTEINASE; CATHEPSIN G; CYSTEINE PROTEINASE; CYTOCHALASIN D; FORMALDEHYDE; HUMAN NEUTROPHIL ALLOANTIGEN 2 ANTIBODY; HUMAN NEUTROPHIL ALLOANTIGEN 3A ANTIBODY; INDOLEACETIC ACID; IODOACETAMIDE; LEUKOCYTE ELASTASE; LUCIGENIN; METALLOPROTEINASE; MYELOBLASTIN; N ALPHA TOSYL LEVO LYSINE CHLOROMETHYL KETONE HYDROCHLORIDE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG; CD177 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HNA-3A ANTIGEN, HUMAN;

ACTIN POLYMERIZATION; AGGLUTINATION TEST; ARTICLE; CELL FUNCTION; CELL ISOLATION; CHEMOLUMINESCENCE; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; ENZYME ACTIVITY; ENZYME MECHANISM; GRANULOCYTE AGGLUTINATION TEST; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE AGGREGATION; NEUTROPHIL; PLASMA CELL; PRIORITY JOURNAL; RESPIRATORY BURST; TRANSFUSION RELATED ACUTE LUNG INJURY; ANTIGEN ANTIBODY REACTION; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; METABOLISM;

AGGLUTINATION; GPI-LINKED PROTEINS; HUMANS; ISOANTIGENS; NEUTROPHILS; RECEPTORS, CELL SURFACE; SERINE PROTEASES; SERINE PROTEINASE INHIBITORS;

EID: 84944281427     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12292     Document Type: Article

References (37)

1. Bux J: Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100:122-128
2. Keller-Stanislawski B, Reil A, Günay S, et al.: Frequency and severity of transfusion-related acute lung injury-German haemovigilance data (2006-2007). Vox Sang 2010; 98:70-77
3. Flesch B, Petershofen E, Bux J: TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine. Tissue Antigens 2011; 78:1-7
4. Hashimoto M, Saigo K, Jyokei Y, et al.: Albumin attenuates neutrophil activation induced by stimulators including antibodies against neutrophil-specific antigens. Transfus Apher Sci 2005; 33:289-298
5. Davoren A, Curtis B, Shulman I, et al.: TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43:641-645
6. Lima J, Reddy VV, Marques MB: Systemic neutrophilic aggregates in transfusion-related acute lung injury. Transfusion 2010; 50:1427-1428
7. Greinacher A, Wesche J, Hammer E, et al.: Characterization of the human neutrophil alloantigen-3a. Nat Med 2010; 16:45-48
8. Witko-Sarsat V, Rieu P, Descamps-Latscha B, et al.: Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000; 80:617-653
9. Sengeløv H, Kjeldsen L, Borregaard N: Control of exocytosis in early neutrophil activation. J Immunol 1993; 150:1535-1543
10. Faurschou M, Borregaard N: Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5:1317-1327
11. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89:3503-3521
12. Pham CT. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol 2008; 40:1317-1333.
13. Steinberg J, Halter J, Schiller HJ, et al.: Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 2003; 111:185-195
14. Moraes TJ, Zurawska JH, Downey GP: Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 2006; 13:21-27
15. Hiemstra P, Van Wetering S, Stolk J: Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: effects on pulmonary epithelium. Eur Respir J 1998; 12:1200-1208
16. Pham CT: Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006; 6:541-550
17. Kim YC, Shin JE, Lee SH, et al.: Membrane-bound proteinase 3 and PAR2 mediate phagocytosis of non-opsonized bacteria in human neutrophils. Mol Immunol 2011; 48:1966-1974
18. Barna JB, Kew RR: Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases. Inflammation 1995; 19:561-574
19. Korkmaz B, Horwitz MS, Jenne DE, et al.: Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev 2010; 62:726-759
20. Reil A, Wesche J, Greinacher A, et al.: Geno-and phenotyping and immunogenicity of HNA-3. Transfusion 2011; 51:18-24
21. Verheugt F, Borne A, Decary F, et al.: The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br J Haematol 1977; 36:533-544
22. Berthold T, Muschter S, Schubert N, et al.: Impact of priming on the response of neutrophils to human neutrophil alloantigen-3a antibodies. Transfusion 2014; doi:10.1111/trf.12898 [Epub ahead of print].
23. Flesch BK, Wesche J, Berthold T, et al.: Expression of the CTL2 transcript variants in human peripheral blood cells and human tissues. Transfusion 2013; 53:3217-3223
24. Bauer S, Abdgawad M, Gunnarsson L, et al.: Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J Leukoc Biol 2007; 81:458-464
25. Fung YL, Silliman CC: The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev 2009; 23:266-283
26. Herbert B, Galvani M, Hamdan M, et al.: Reduction and alkylation of proteins in preparation of two-dimensional map analysis: Why, when, and how? Electrophoresis 2001; 22:2046-2057
27. Campbell EJ, Campbell MA, Owen CA: Bioactive proteinase 3 on the cell surface of human neutrophils: quantification, catalytic activity, and susceptibility to inhibition. J Immunol 2000; 165:3366-3374
28. Feinstein G, Malemud C, Janoff A. The inhibition of human leucocyte elastase and chymotrypsin-like protease by elastatinal and chymostatin. Biochim Biophys Acta 1976; 429:925-932.
29. Kurinov I, Harrison R: Two crystal structures of the leupeptin-trypsin complex. Protein Sci 1996; 5:752-758
30. O'Donnell-Tormey J, Quigley JP: Detection and partial characterization of a chymostatin-sensitive endopeptidase in transformed fibroblasts. Proc Natl Acad Sci 1983; 80:344-348
31. Savory PJ, Rivett AJ: Leupeptin-binding site (s) in the mammalian multicatalytic proteinase complex. Biochem J 1993; 289:45-48
32. Mihara K, Ramachandran R, Renaux B, et al.: Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). J Biol Chem 2013; 288:32979-32990
33. Si-Tahar M, Pidard D, Balloy V, et al.: Human neutrophil elastase proteolytically activates the platelet integrin alphaIIb\beta3 through cleavage of the carboxyl terminus of the alphaIIb subunit heavy chain. J Biol Chem 1997; 272:11636-11647
34. Sambrano GR, Huang W, Faruqi T, et al.: Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem 2000; 275:6819-6823
35. Bayat B, Tjahjono Y, Sydykov A, et al.: Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33:2538-2548
36. Silliman CC, Curtis BR, Kopko PM, et al.: Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007; 109:1752-1755
37. Gobbetti T, Cenac N, Motta J-P, et al.: Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine. Am J Pathol 2012; 180:141-152